Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy

Vasu S.; Wu H.; Satoskar A.; Puto M.; Roddy J.; Blum W.; Klisovic R.; Andritsos L.; Hofmeister C.; Benson D. M.; Efebera Y.; Jaglowski S.; Penza S.; Cohen D.; Devine S.; Cataland S.

首页> 外文期刊>Bone marrow transplantation >Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy

【24h】

Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy

机译：依库丽单抗治疗同种异体造血细胞移植相关的血栓性微血管病的成人

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2016年第9期|共4页
作者
Vasu S.; Wu H.; Satoskar A.; Puto M.; Roddy J.; Blum W.; Klisovic R.; Andritsos L.; Hofmeister C.; Benson D. M.; Efebera Y.; Jaglowski S.; Penza S.; Cohen D.; Devine S.; Cataland S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy [J] . Vasu S., Wu H., Satoskar A., Bone marrow transplantation . 2016,第9期

机译：依库丽单抗治疗同种异体造血细胞移植相关的血栓性微血管病的成人
2. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC [J] . Fiore Sicre de Fontbrune, Claire Galambrun, Anne Sirvent, Transplantation: Official Journal of the Transplantation Society . 2015,第9期

机译：依库丽单抗在同种异体干细胞移植相关血栓性微血管病患者中的应用：来自SFGM-TC的研究
3. ECULIZUMAB POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA). [J] . Mizuno K., Fukuda T., Dixon B. P., Clinical Pharmacology and Therapeutics . 2016,第Suppla1期

机译：造血干细胞移植患者伴有血栓性微血管病（HSCT-TMA）的患者中依库仑单抗的种群药代动力学和药物动力学。
4. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
5. Long-Term Bone Mineral Density Loss Following Autologous and Allogeneic Hematopoietic Cell Transplantation and Effectiveness of Bone Loss Therapies to Combat the Loss. [D] . Croudy, Christopher M. 2012

机译：自体和同种异体造血细胞移植后的长期骨矿物质密度损失以及抗击骨损失疗法的有效性。
6. Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation [O] . Ömür Gökmen Sevindik, İnci Alacacıoğlu, Abdullah Katgı, 2015

机译：异基因造血祖细胞移植后与移植相关血栓性微血管病患者使用依库丽单抗的肾脏和神经反应
7. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies [O] . J Khosla, A C Yeh, T R Spitzer, 2017

机译：造血干细胞移植相关血栓性微疗病：目前的范式和新疗法

Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy

著录项

相似文献

相关主题

期刊订阅